"In unserem gynäkologischen Zentrum in Bonn bieten wir Ihnen eine individuelle und empathische frauenärztliche Betreuung mit dem ausgewiesenen Schwerpunkt der Prävention. Unser Leistungsangebot umfasst sämtliche Bereiche der Frauenheilkunde und Geburtshilfe mit Ausnahme größerer Operationen und der assistierten Reproduktion. Sie können sich sicher sein, dass Sie bei uns stets nach neuesten wissenschaftlichen Gesichtspunkten diagnostiziert und behandelt werden. Dabei stehen menschliche Zuwendung und Empathie immer auf einer Stufe mit der professionellen medizinischen Versorgung. Wir freuen uns auf Ihren Besuch bei uns."

During the past decade, Gynäkologisches Zentrum Bonn conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gynäkologisches Zentrum Bonn" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Gilead Sciences" with 1 trials sponsored, "Prof. Wolfgang Janni" with 1 trials sponsored, "Seagen Inc." with 1 trials sponsored and "iOMEDICO AG" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gynäkologisches Zentrum Bonn" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Gynäkologisches Zentrum Bonn" are "Breast Cancer" (3 trials), "HER 2 Negative Breast Cancer" (1 trials), "HER2-negative Metastatic Breast Cancer" (1 trials), "Hormone Receptor Positive Tumor" (1 trials) and "Hormone Receptor-positive Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Gynäkologisches Zentrum Bonn" in a lesser frequency.

Most popular intervention types in "Gynäkologisches Zentrum Bonn" are "Drug" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abemaciclib + Aromatase Inhibitor" (1 trials), "Abemaciclib + Fulvestrant" (1 trials), "Atezolizumab" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gynäkologisches Zentrum Bonn" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Gynäkologisches Zentrum Bonn". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gynäkologisches Zentrum Bonn, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gynäkologisches Zentrum Bonn, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".